Promethera Biosciences rallies Series D funding
Promethera Biosciences SA, a provider of cell-based medicines, has raised 39.7 million euros in Series D financing. The investors included ITOCHU Corporation, Shinsei Capital Partners, Mirae Asset Capital, Korea Investment Partners, Ci:z Investment LLP and Mitsui & Co.
7 May 2019•1 min read
